Want to join the conversation?
$MKC 2Q15 Call-Gordon, CFO: Operating income on reported basis, we expect 4-5% decline from $603MM in 2014. We expect adjusted EPS of $3.47-3.54 for FY15. This is a $0.03 increase from previous guidance reflecting latest tax rate estimates. This range excluding an estimated $0.12 headwind from currency, is an increase of 7-9% from $3.37 in 2014.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.